Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2024 Financial Results
EAGAN, MN / ACCESSWIRE / September 24, 2024 / Dynatronics Corporation (OTC Markets: DYNT) ("Dynatronics" or the "Company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its fourth quarter and fiscal year ended June 30, 2024.
Key Financial Highlights
Note: All financials referenced in this release are in conformity with U.S. Generally Accepted Accounting Principles ("GAAP") and comparisons in this release are to the same period in the prior year unless otherwise noted.
Q4 FY 2024 Financial Highlights
- Total net sales of $7.4 million.
- Gross profit margin of 22.9%.
- Net loss of $0.7 million.
FY 2024 Financial Highlights
- Total net sales of $32.5 million.
- Gross profit margin of 23.5%.
- Net loss of $2.7 million.
FY 2024 Notable Balance Sheet Highlights
- Net cash of $0.5 million.
- As of June 30, 2024, $2.1 million drawn, with $3.8 million available on previously announced working capital asset-based line of credit established on August 1, 2023.
Fiscal Year 2025 Priorities
The Company will continue to introduce new products into the rehabilitation markets they sell, with products planned to support existing and new market segments. The Company expects the new product introductions will provide new incremental revenue and pull-through revenue opportunities. The Company continues to strengthen existing customer relationships, including OEM customers and strategic distribution partners. The company is planning to acquire new customers in conjunction with new products and services launched in the coming year.
Operationally, the Company maintains a focus on improving plant performance to reduce costs and supply chain initiatives to optimize inventory levels, along with customer-centric initiatives to continuously improve service levels.
Resignation of Brian M. Larkin as a Member of the Board of Directors
The Company announced today the resignation of Brian Larkin on September 24, 2024 as a member of Dynatronics' Board of Directors. The Company does not have any immediate plans to fill the Board vacancy created by Mr. Larkin's resignation.
Erin Enright, Chair of the Board of Directors, expressed her appreciation for Mr. Larkin's service on Dynatronics' board since 2015. "Brian has been an important part of the Company's progress over these past nine years, helping with strategy, commercial planning and acquisitions. We will miss his insight and contributions and thank him for all of his efforts."
Mr. Larkin commented: "It has been an honor and a pleasure to serve as a Director at Dynatronics for the past 9 years. I wish the team continued success and as a shareholder will monitor with interest the performance of the company under Brian Baker's thoughtful leadership."
About Dynatronics Corporation
Dynatronics is a leading medical device company committed to providing high-quality products designed to improve practitioner workspaces and workflows and to accelerate patients achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann®, and PROTEAM™, among others. More information is available at www.dynatronics.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Those statements include references to the Company's expectations and similar statements. Such forward-looking statements reflect the views of management at the time such statements are made. These statements include our statements regarding the Company's expected overall performance, expectations regarding net sales, distribution of net sales, and selling general and administrative costs in fiscal year 2024, and uncertainties related to the broader economic environment, including higher raw material, delivery and shipment costs, supply chain disruptions, extended handling times and delays or disruption in procedure volume and volatility resulting from continued execution of the Company's business optimization strategy. These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in the Company's annual, quarterly, and other reports filed with the Securities and Exchange Commission. Dynatronics does not undertake to update its forward-looking statements, whether as a result of new information, future events, or otherwise.
Summary Financial Results
The following is a summary of operating results for the periods ended June 30, 2024, and June 30, 2023, the balance sheet highlights June 30, 2024, and June 30, 2023, and cash flow for periods ended June 30, 2024, and June 30, 2023.
Summary Selected Financial Data
Statements of Operations Highlights
In thousands, except share and per share amounts
| | | Quarter Ended | | | Year Ended | |
| | | June 30 | | | June 30 | |
| | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
| | | | | | | | | | | | | |
| Net sales | $ | 7,376 | | $ | 8,438 | | $ | 32,534 | | $ | 40,609 | |
| Cost of sales | | 5,685 | | | 7,201 | | | 24,899 | | | 30,459 | |
| Gross Profit | | 1,691 | | | 1,237 | | | 7,635 | | | 10,150 | |
| | | 22.9% | | | 14.7% | | | 23.5% | | | 25.0% | |
| | | | | | | | | | | | | |
| Selling, general and administrative expenses | | 2,250 | | | 3,593 | | | 9,908 | | | 15,002 | |
| Other (expense) income, net | | (129 | ) | | (25 | ) | | (425 | ) | | (121 | ) |
| Net income (loss) | $ | (688 | ) | $ | (2,381 | ) | $ | (2,698 | ) | $ | (4,973 | ) |
| | | | | | | | | | | | | |
| Preferred stock dividend, in common stock, issued or to be issued | | (159 | ) | | (172 | ) | | (731 | ) | | (691 | ) |
| Net income (loss) attributable to common stockholders | $ | (847 | ) | $ | (2,553 | ) | $ | (3,429 | ) | $ | (5,664 | ) |
| | | | | | | | | | | | | |
| Net loss attributable to common stockholders per common share - basic and diluted | $ | (0.16 | ) | $ | (0.63 | ) | $ | (1.00 | ) | $ | (1.46 | ) |
| Weighted-average common shares outstanding - basic and diluted | | 5,308,519 | | | 4,039,618 | | | 3,421,606 | | | 3,870,670 | |
Balance Sheet Highlights
In thousands
| | | June 30, 2024 | | | June 30, 2023 | |
| Cash and cash equivalents and restricted cash | $ | 534 | | $ | 553 | |
| Trade accounts receivable, net | | 3,445 | | | 3,722 | |
| Inventories, net | | 5,594 | | | 7,403 | |
| Prepaids & other | | 985 | | | 742 | |
| Total current assets | | 10,558 | | | 12,420 | |
| | | | | | | |
| Non-current assets | | 15,383 | | | 17,644 | |
| Total assets | $ | 25,941 | | $ | 30,063 | |
| | | | | | | |
| Accounts payable | $ | 2,712 | | $ | 4,530 | |
| Accrued payroll and benefits expense | | 566 | | | 878 | |
| Accrued expenses | | 726 | | | 891 | |
| Other current liabilities | | 1,579 | | | 1,642 | |
| Line of credit | | 2,122 | | | - | |
| Total current liabilities | | 7,705 | | | 7,941 | |
| | | | | | | |
| Non-current liabilities | | 4,075 | | | 5,265 | |
| Total liabilities | | 11,780 | | | 13,206 | |
| | | | | | | |
| Stockholders' equity | | 14,160 | | | 16,857 | |
| Total liabilities and stockholders' equity | $ | 25,941 | | $ | 30,063 | |
Cash Flow Highlights
In thousands
| | | Quarter Ended | | | Twelve Months Ended | |
| | | June 30 | | | June 30 | |
| | | 2024 | | | 2023 | | | 2024 | | | 2023 | |
| | | | | | | | | | | | | |
| Net loss | $ | (688 | ) | $ | (2,381 | ) | $ | (2,698 | ) | $ | (4,973 | ) |
| | | | | | | | | | | | | |
| Depreciation and amortization | | 320 | | | 341 | | | 1,304 | | | 1,349 | |
| Stock-based compensation | | 3 | | | 22 | | | 2 | | | 131 | |
| (Gain) loss on sale of property and equipment | | - | | | - | | | 41 | | | - | |
| Receivables | | 272 | | | 645 | | | 277 | | | 1,695 | |
| Inventory | | 590 | | | 2,300 | | | 1,809 | | | 4,668 | |
| Prepaid and other assets | | 558 | | | (226 | ) | | 120 | | | (159 | ) |
| Accounts payable, accrued expenses, and other liabilities | | (811 | ) | | (734 | ) | | (2,466 | ) | | (2,339 | ) |
| Net cash provided by (used in) operating activities | | 244 | | | (33 | ) | | (1,611 | ) | | 372 | |
| | | | | | | | | | | | | |
| Net cash used in investing activities | | (2 | ) | | (10 | ) | | (243 | ) | | (187 | ) |
| | | | | | | | | | | | | |
| Payments on non-current liabilities | | (304 | ) | | (74 | ) | | 1,835 | | | (333 | ) |
| Net cash used in financing activities | | (304 | ) | | (74 | ) | | 1,835 | | | (333 | ) |
| | | | | | | | | | | | | |
| Net change in cash and cash equivalents | | (62 | ) | | (117 | ) | | (19 | ) | | (148 | ) |
| Cash and cash equivalents at beginning of the period | | 596 | | | 670 | | | 553 | | | 701 | |
| Cash and cash equivalents at end of the period | $ | 534 | | $ | 553 | | $ | 534 | | $ | 553 | |
Contact:
Dynatronics Corporation
Investor Relations
ir@dynatronics.com
For additional information, please visit: www.dynatronics.com
Connect with Dynatronics on LinkedIn
SOURCE: Dynatronics Corporation
